HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Jeffrey L Browning Selected Research

Lymphotoxin-alpha (Lymphotoxin)

3/2014Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA.
1/2014Lymphotoxin-LIGHT pathway regulates the interferon signature in rheumatoid arthritis.
5/2013Lymphotoxin β receptor mediates caspase-dependent tumor cell apoptosis in vitro and tumor suppression in vivo despite induction of NF-κB activation.
11/2012Lymphotoxin β receptor signaling promotes development of autoimmune pancreatitis.
7/2012Regulation of T(H)2 development by CXCR5+ dendritic cells and lymphotoxin-expressing B cells.
2/2012Donor B-cell alloantibody deposition and germinal center formation are required for the development of murine chronic GVHD and bronchiolitis obliterans.
10/2009A lymphotoxin-driven pathway to hepatocellular carcinoma.
6/2008Inhibition of the lymphotoxin pathway as a therapy for autoimmune disease.
9/2003A role for surface lymphotoxin in experimental autoimmune encephalomyelitis independent of LIGHT.
8/2003Lymphotoxin/light, lymphoid microenvironments and autoimmune disease.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Jeffrey L Browning Research Topics

Disease

3Neoplasms (Cancer)
12/2015 - 10/2006
3Autoimmune Diseases (Autoimmune Disease)
01/2014 - 08/2003
2Infection
04/2014 - 07/2012
2Rheumatoid Arthritis
01/2014 - 07/2006
2Inflammation
01/2013 - 07/2003
1Skin Diseases
11/2015
1Hepatitis B
03/2014
1Pancreatitis
11/2012
1Fibrosis (Cirrhosis)
02/2012
1Bronchiolitis Obliterans
02/2012
1Brain Edema (Cerebral Edema)
12/2010
1Hepatocellular Carcinoma (Hepatoma)
10/2009
1Hepatitis
10/2009
1Carcinoma (Carcinomatosis)
10/2006
1Colorectal Neoplasms (Colorectal Cancer)
10/2006
1Immune System Diseases (Immune Disorders)
07/2006
1Lymphoma (Lymphomas)
07/2006
1Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
09/2003
1Arthritis (Polyarthritis)
07/2003
1Experimental Arthritis
07/2003
1Necrosis
07/2002

Drug/Important Bio-Agent (IBA)

11Lymphotoxin-alpha (Lymphotoxin)IBA
03/2014 - 07/2003
2CytokinesIBA
12/2015 - 10/2009
2Immunoglobulins (Immunoglobulin)IBA
02/2012 - 06/2008
2Lymphotoxin beta ReceptorIBA
06/2008 - 10/2006
1Diffuse systemic sclerosisIBA
11/2015
1Interferon Type IIBA
04/2014
1Antiviral Agents (Antivirals)IBA
03/2014
1InterferonsIBA
01/2014
1Biological Markers (Surrogate Marker)IBA
01/2013
1TrypsinIBA
11/2012
1AutoantibodiesIBA
11/2012
1Adrenal Cortex Hormones (Corticosteroids)IBA
11/2012
1Chemokine CXCL13IBA
07/2012
1AntigensIBA
07/2012
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
02/2012
1HormonesIBA
12/2010
1AntibodiesIBA
10/2006
1rituximab (Mabthera)FDA Link
07/2006
1Complement System Proteins (Complement)IBA
07/2003
1Lymphotoxin-betaIBA
07/2003
1Antigen-Antibody Complex (Immune Complex)IBA
07/2003
1CollagenIBA
07/2003
1B-Cell Activating FactorIBA
07/2002

Therapy/Procedure

1Therapeutics
03/2014
1Heterologous Transplantation (Xenotransplantation)
10/2006